Business Trends– category –
-
Century Therapeutics Targets Q4 2026 IND Submission for iPSC-Derived CNTY-813 in Type 1 Diabetes, Advances CAR-iT Cell Therapy CNTY-308 Towards Clinical Trials This Year
Century Therapeutics, Inc. (Press Release) USA Overview Century Therapeutics announced that it has completed its pre-IND meeting with the FDA for CNTY-813, an iPSC-derived cell therapy for Type 1 diabetes, targeting an Investigational Ne... -
Fate Therapeutics Initiates Phase 2 Trial for iPSC-Derived Off-the-Shelf CAR T-Cell Therapy FT819 in Lupus Nephritis, Gains FDA IND Approval for Autoimmune FT839
Fate Therapeutics, Inc. (Press Release) USA Overview Fate Therapeutics reported significant advancements in its iPSC-derived off-the-shelf CAR T-cell immunotherapy pipeline, with the first patient dosed in the Phase 2 RECLAIM-LN study of... -
Intellia Therapeutics Advances CRISPR Gene Editing: Lonvo-z Achieves Phase 3 Success for HAE, Targeting Mid-2027 U.S. Launch; Nex-z Phase 3 Enrollment Resumes for ATTR
Intellia Therapeutics, Inc. (Press Release) USA Overview Intellia Therapeutics reported positive Phase 3 results for lonvo-z in hereditary angioedema (HAE), with a Biologics License Application (BLA) submission to the FDA planned for H2 ... -
CrystalO Biopharma Signs Collaboration and Licensing Deal with Almirall for AI-Driven Skin Disease Drug Discovery, Valued Up to €254.5 Million
Insight, China's Pharmaceutical Industry China Overview CrystalO Biopharma has signed a collaboration and licensing agreement with Almirall, a global biopharmaceutical company, to develop innovative drug candidates for skin diseases. The... -
Aisot Technologies Raises €2.13 Million Seed Extension for AI-Powered Portfolio Intelligence Platform Targeting Institutional Investors
Startupticker.ch Switzerland Overview Zurich-based Aisot Technologies has raised €2.13 million in a Seed extension round for its AI-powered portfolio intelligence platform for institutional investors. Spun off from ETH Zurich, the compan... -
River AI Secures $1.1 Billion in Funding Across Seed and Series A Rounds from NVIDIA, AMD, and Others to Develop Personal AI Stack
Menlo Times USA Overview River AI, a startup developing a new stack for personal AI, has secured $1.1 billion in funding across Series Seed and Series A rounds, led by General Catalyst and AMP PBC, with strategic investment from NVIDIA a... -
Skan AI Raises $63 Million to Enhance Platform for Observing and Modeling Employee Workflows, Launching New Enterprise AI Automation Products
VentureBeat USA Overview Enterprise AI startup Skan AI secured $63 million in Series C funding to enhance its platform, which observes and models how employees perform tasks across software. To address the high failure rate of generative... -
AMD Acquires Taalas to Enhance Compute Solutions for Rapidly Growing AI Inference Market
Globe Newswire USA Overview AMD has announced a definitive agreement to acquire Taalas, a pioneer in specialized AI inference silicon, aiming to strengthen its AI roadmap. This acquisition will enhance AMD's compute solutions for the rap... -
SpaceX to Finalize $60 Billion All-Stock Acquisition of AI Coding Assistant Developer Anysphere
SatNews USA Overview SpaceX is nearing the finalization of its $60 billion all-stock acquisition of Anysphere, the company behind the AI-powered coding assistant Cursor. This strategic move aims to significantly expand SpaceX's internal ... -
SpaceX/xAI Acquires AI Coding Platform Cursor Amidst $600 Billion Pending M&A Deals
DealRoom.net USA Overview As of August 2026, approximately 20 M&A deals valued at $600 billion are pending completion. Notably, SpaceX acquired AI coding platform Cursor, to be integrated into xAI's computing and model stack, which S...
